Glutathione depletion modulates gene expression in HepG2 cells via activation of protein kinase C alpha

Buthionine sulphoximine (BSO; 1 mM) resulted in the depletion of glutathione (GSH) in HepG2 cells to 17 ± 1.5% within 24 h. This was not associated with apoptotic or necrotic cell death over this time period. Use of a human (Phase 1 ®) cDNA custom toxicology-array and a larger scale (>10,000 gene...

Full description

Saved in:
Bibliographic Details
Published inToxicology (Amsterdam) Vol. 216; no. 2; pp. 168 - 180
Main Authors White, Angela T., Spence, Fiona J., Chipman, James K.
Format Journal Article
LanguageEnglish
Published Shannon Elsevier Ireland Ltd 15.12.2005
Amsterdam Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Buthionine sulphoximine (BSO; 1 mM) resulted in the depletion of glutathione (GSH) in HepG2 cells to 17 ± 1.5% within 24 h. This was not associated with apoptotic or necrotic cell death over this time period. Use of a human (Phase 1 ®) cDNA custom toxicology-array and a larger scale (>10,000 gene) Affymetrix U95Av2 array identified a total of 48 and 104 genes, respectively, with a statistically significant (and >1.5-fold) change in expression. A total of 64 differentially expressed genes (6 of which were confirmed by real-time polymerase chain reaction) were suggestive of protein kinase C (PKC) activation. Activation of PKC-α (but not βI or δ) was demonstrated at 24 h through activity measurements and through Western blot analysis of membrane-associated PKC-α protein. Activation did not occur in the presence of additional γ-glutamylcysteine to prevent GSH depletion. Activation of PKC-α by GSH-depletion may, at least in part, be mediated by thiol oxidation and may contribute to a survival signal. If sustained, the activation may be important in non-genotoxic carcinogenesis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0300-483X
1879-3185
DOI:10.1016/j.tox.2005.08.001